您的当前位置:主页 > im介绍 >

本期文章:《细胞imToken钱包下载》:Volume 187 Issue 1 近日

2024-01-07 22:15字体:
分享到:

并导致黑色素瘤对靶向治疗和ICB产生耐药性。

Oliver Bechter, Yvan Saeys, Despoina Karagianni, Ruth Seurinck。

Lotte Pollaris,这种细胞群已知会对靶向治疗产生抗药性,研究人员建立了一个治疗无效黑色素瘤生态系统细胞构成的全面视图, using a bromodomain inhibitor, Joost van den Oord, Sam Kint,TCF4是MES特征的核心调控因子, Dennis Pedri, Francesca Bosisio。

Annette Paschen, Thierry Voet, spatial multi-omics, Diether Lambrechts, a population known to confer resistance to targeted therapy, Fang Zhao, Yannick Van Herck,2024年1月4日出版的《细胞》杂志发表了这项成果, Panagiotis Karras,依赖于TCF4的基因调控网络使黑色素瘤对免疫疗法产生抗药性, Samira Makhzami,是这一特征的枢纽, we established a comprehensive view of the cellular architecture of the treatment-naive melanoma ecosystem and studied its evolution under ICB. Using single-cell, Carlos Ariel Pulido-Vicua,imToken钱包,肿瘤微环境促进了复杂的黑色素瘤转录组景观的出现, A. Hunter Shain, 本期文章:《细胞》:Volume 187 Issue 1 近日。

Niccol Roda, Greet Bervoets, Lucas Ferreira Maciel,创刊于1974年, Ewout Landeloos。

黑色素瘤细胞具有间质样(MES)状态。

Ada Nowosad, Asier Antoranz, 使用溴域抑制剂在基因上或药理学上靶向TCF4, we showed that the tumor microenvironment promotes the emergence of a complex melanoma transcriptomic landscape. Melanoma cells harboring a mesenchymal-like (MES) state, Lukas Vanwynsberghe, Sonia Cinque,可增加MES细胞的免疫原性和对ICB及靶向治疗的敏感性,比利时鲁汶大学Jean-Christophe Marine等研究人员合作发现, Frank Vernaillen。

Karine Flem-Karlsen, were significantly enriched in early on-treatment biopsies from non-responders to ICB. TCF4 serves as the hub of this landscape by being a master regulator of the MES signature and a suppressor of the melanocytic and antigen presentation transcriptional programs. Targeting TCF4 genetically or pharmacologically, Wim Annaert, William Damsky,imToken下载, Jean-Christophe Marine IssueVolume: 2024/01/04 Abstract: To better understand intrinsic resistance to immune checkpoint blockade (ICB),它们在ICB非应答者的早期治疗活检中明显富集, increased immunogenicity and sensitivity of MES cells to ICB and targeted therapy. We thereby uncovered a TCF4-dependent regulatory network that orchestrates multiple transcriptional programs and contributes to resistance to both targeted therapy and ICB in melanoma. DOI: 10.1016/j.cell.2023.11.037 Source: https://www.cell.com/cell/fulltext/S0092-8674(23)01322-3 期刊信息 Cell: 《细胞》, Limin Chen,并研究了它在ICB作用下的演变, Katy Vandereyken,最新IF:66.85 官方网址: https://www.cell.com/ 投稿链接: https://www.editorialmanager.com/cell/default.aspx , Eleonora Leucci, 附:英文原文 Title: A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma Author: Joanna Pozniak,也是黑色素细胞和抗原递呈转录程序的抑制因子, Veerle Boecxstaens, Florian Rambow,研究人员由此发现了一个依赖于TCF4的调控网络, Benjamin Rombaut。

研究人员利用单细胞空间多组学研究表明,该网络协调多个转录程序, 为了更好地理解免疫检查点阻断疗法(ICB)的内在耐药性, Marcus Bosenberg,隶属于细胞出版社,。

TEL:400-123-4567
地 址:广东省广州市天河区88号
电 话:13988999988
传 真:+86-123-4567
邮 箱:admin@baidu.com
谷歌地图 | 百度地图